Mindfulness Based Stress Reduction: Supportive Treatment for Adult Patients With Cancer and Their Partners
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01074528 |
Recruitment Status :
Completed
First Posted : February 24, 2010
Last Update Posted : July 17, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Cancer | Behavioral: mindfulness based stress reduction program | Not Applicable |
Patients with breast cancer often experience anxiety, depression, stress and reduced quality of life. As such, there is an increased interest in the implementation of the Mindfulness-Based Stress Reduction program as an additional supportive treatment. MBSR is a structured group program that aims at reducing stress levels by enhancing awareness of the present moment in combination with a non-judgemental attitude.
The study evaluates the effects of an 8-week MBSR program on quality of life, mood, depression, stress and coping skills in breast cancer patients.
Breast cancer patients of the Breast Clinic of the Universitair Ziekenhuis Brussel participate in the MBSR program. Before and after the training program patients filled out questionnaires evaluating quality of life, coping skills, emotional functioning, stress and aspects of mindfulness.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 150 participants |
Allocation: | Non-Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Supportive Care |
Official Title: | Mindfulness Based Stress Reduction: Supportive Treatment for Adult Patients With Cancer and Their Partners |
Study Start Date : | April 2010 |
Actual Primary Completion Date : | April 2017 |
Actual Study Completion Date : | May 2017 |
Arm | Intervention/treatment |
---|---|
Experimental: mindfulness based stress reduction
8-week mindfulness based stress reduction program
|
Behavioral: mindfulness based stress reduction program
8-week mindfulness training program
Other Name: MBSR |
No Intervention: control group
patients who have to wait before entering the MBSR program or who do not want to follow this program
|
- quality of life (FACT) before training [ Time Frame: day 1 ]
- Quality of life (FACT) after training [ Time Frame: day 48 ]
- Cancer Coping Questionnaire (CCQ) [ Time Frame: day 1 ]
- Profile Of Mood Scale (POMS) [ Time Frame: day 1 ]
- Perceived Stress Scale (PSS) [ Time Frame: day 1 ]
- Freiburg Mindfulness Scale [ Time Frame: day 1 ]
- Cancer Coping Questionnaire (CCQ) [ Time Frame: day 48 ]
- Profile of Mood Scale (POMS) [ Time Frame: day 48 ]
- Perceived Stress Scale (PSS) [ Time Frame: day 48 ]
- Freiburg Mindfulness Inventory (FMI) [ Time Frame: day48 ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 70 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
For patients:
- Cancer diagnosis
- Between the age of 18 until 70
- Dutch speaking
For partners:
- between the age of 18 until 70
- dutch speaking
Exclusion Criteria:
for patients and partners:
- Ongoing radiation therapy
- Psychiatric disorders
- Previous experience with mindfulness or meditation related techniques
- Pregnancy
- No or insufficient understanding of the Dutch language

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01074528
Belgium | |
UZ Brussel | |
Brussel, Belgium, 1090 |
Principal Investigator: | Christiaan Schotte, PhD | Universitair Ziekenhuis Brussel |
Responsible Party: | Prof. Dr. Christiaan Schotte, Professor, Belgian Federal Public Service, Food Chain Safety and Environment |
ClinicalTrials.gov Identifier: | NCT01074528 |
Other Study ID Numbers: |
SCV2010 |
First Posted: | February 24, 2010 Key Record Dates |
Last Update Posted: | July 17, 2017 |
Last Verified: | July 2017 |
cancer patients relatives or partners of cancer patients |